Almiba (L-carnitine) oral solution 120 ml. vial with syringe

$29.10

Manufacturer: Spain

As a dietary supplement to the diet as an auxiliary component:

  • when caring for premature newborns;
  • with hypotrophy and hypotension, respiratory distress syndrome in newborns;
  • with deterioration of appetite, lack of body weight;
  • during hemodialysis;
  • with chronic disorders of cerebral blood circulation, dementia, cognitive disorders, depression, asthenia;
  • with increased mental, psychological and emotional stress;
  • with cardiomyopathy, disorders of myocardial metabolism with coronary artery disease, atherosclerosis;
  • after a myocardial infarction, acute cerebrovascular accident, after surgery during the rehabilitation period;
  • with diabetes, mild forms of thyrotoxicosis;
  • with physical exhaustion, intense physical exertion in athletes (as an anabolic and adaptogen);
  • with obesity;
  • with non-alcoholic steatohepatitis;
  • with placental insufficiency and toxicosis in pregnant women;
  • with male and female infertility;
  • in kidney diseases accompanied by increased loss of carnitine;
  • with skin diseases.
Category:

Description

Ingredients

1 ml contains – active substances: L-carnitine 400 mg;

excipients: sorbitol, citric acid, sodium benzoate, potassium sorbate, red fruit flavoring.

Nutrient (food) and energy value (calories)

Per 100 grams: proteins – 2.2 g, carbohydrates – 1.8 g, fats – 0.1 g; 31 kcal / 129 kJ.

Indication

As a dietary supplement to the diet as an auxiliary component:

  • when caring for premature newborns;
  • with hypotrophy and hypotension, respiratory distress syndrome in newborns;
  • with deterioration of appetite, lack of body weight;
  • during hemodialysis;
  • with chronic disorders of cerebral blood circulation, dementia, cognitive disorders, depression, asthenia;
  • with increased mental, psychological and emotional stress;
  • with cardiomyopathy, disorders of myocardial metabolism with coronary artery disease, atherosclerosis;
  • after a myocardial infarction, acute cerebrovascular accident, after surgery during the rehabilitation period;
  • with diabetes, mild forms of thyrotoxicosis;
  • with physical exhaustion, intense physical exertion in athletes (as an anabolic and adaptogen);
  • with obesity;
  • with non-alcoholic steatohepatitis;
  • with placental insufficiency and toxicosis in pregnant women;
  • with male and female infertility;
  • in kidney diseases accompanied by increased loss of carnitine;
  • with skin diseases.

Directions

Usual doses for newborns and children under 12 years of age are 50-100 mg/kg per day (0.13-0.25 ml), divided into 2-3 doses.

Children from 12 years old and adults Almibu is recommended to use 1-3 g per day (2.5 – 7.5 ml). The course of administration is 1-3 months. If necessary, the course can be repeated.

Consultation with a doctor is recommended before use. Do not use as a substitute for a full and balanced diet! Do not exceed the recommended daily dose!

Contraindications of Almiba (L-carnitine)

  • Individual intolerance of components.
  • Sensitivity to the dietary supplement must be carefully assessed during the first week of levocarnitine use and after each dose increase.